353 related articles for article (PubMed ID: 21596035)
1. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
Liu W; Shen Y; Plane JM; Pleasure DE; Deng W
Exp Neurol; 2011 Aug; 230(2):227-39. PubMed ID: 21596035
[TBL] [Abstract][Full Text] [Related]
2. A neuroprotective derivative of erythropoietin that is not erythropoietic.
Doggrell SA
Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
[TBL] [Abstract][Full Text] [Related]
3. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
Villa P; van Beek J; Larsen AK; Gerwien J; Christensen S; Cerami A; Brines M; Leist M; Ghezzi P; Torup L
J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629
[TBL] [Abstract][Full Text] [Related]
4. Carbamylated erythropoietin ameliorates hypoxia-induced cognitive and behavioral defects with the generation of choline acetyltransferase-positive neurons.
Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
J Neurosci Res; 2013 Jan; 91(1):73-82. PubMed ID: 23074165
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
Ding J; Wang J; Li QY; Yu JZ; Ma CG; Wang X; Lu CZ; Xiao BG
Mol Neurobiol; 2017 Sep; 54(7):5051-5060. PubMed ID: 27541284
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia.
Falahati S; Breu M; Waickman AT; Phillips AW; Arauz EJ; Snyder S; Porambo M; Goeral K; Comi AM; Wilson MA; Johnston MV; Fatemi A
Dev Neurosci; 2013; 35(2-3):182-96. PubMed ID: 23445614
[TBL] [Abstract][Full Text] [Related]
8. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
[TBL] [Abstract][Full Text] [Related]
9. The p38α MAPK Deletion in Oligodendroglia does not Attenuate Myelination Defects in a Mouse Model of Periventricular Leukomalacia.
Chung SH; Biswas S; Sohn J; Jiang P; Dehghan S; Marzban H; Deng W
Neuroscience; 2018 Aug; 386():175-181. PubMed ID: 29966722
[TBL] [Abstract][Full Text] [Related]
10. Emerging concepts in periventricular white matter injury.
Back SA; Rivkees SA
Semin Perinatol; 2004 Dec; 28(6):405-14. PubMed ID: 15693397
[TBL] [Abstract][Full Text] [Related]
11. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
13. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
[TBL] [Abstract][Full Text] [Related]
14. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia.
Haynes RL; Folkerth RD; Keefe RJ; Sung I; Swzeda LI; Rosenberg PA; Volpe JJ; Kinney HC
J Neuropathol Exp Neurol; 2003 May; 62(5):441-50. PubMed ID: 12769184
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
[TBL] [Abstract][Full Text] [Related]
16. Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia.
Fantacci M; Bianciardi P; Caretti A; Coleman TR; Cerami A; Brines M; Samaja M
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17531-6. PubMed ID: 17090665
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.
Keller M; Yang J; Griesmaier E; Gorna A; Sarkozy G; Urbanek M; Gressens P; Simbruner G
Neurobiol Dis; 2006 Nov; 24(2):357-66. PubMed ID: 16959492
[TBL] [Abstract][Full Text] [Related]
18. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R
Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model.
Mizuno K; Hida H; Masuda T; Nishino H; Togari H
Neonatology; 2008; 94(4):255-66. PubMed ID: 18784421
[TBL] [Abstract][Full Text] [Related]
20. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
Follett PL; Deng W; Dai W; Talos DM; Massillon LJ; Rosenberg PA; Volpe JJ; Jensen FE
J Neurosci; 2004 May; 24(18):4412-20. PubMed ID: 15128855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
